Skip to content
ppharmaranks
Menu
Class IOngoing

Ropivacaine Hydrochloride Injection recall

FDA recall D-0402-2025 · initiated Apr 17, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated May 14, 2025How we research

Amneal Pharmaceuticals, LLC recalled Ropivacaine Hydrochloride Injection in Apr 2025 — an FDA Class I recall (D-0402-2025) because Presence of Particulate Matter.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Presence of Particulate Matter

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #'s: AL240003, AL240004, Exp.: 01/31/2026

Quantity recalled: 62 (12x100mL) bags

Details

Product
Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)
Recalling company
Amneal
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the US
Initiated
Apr 17, 2025
FDA report date
May 14, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Ropivacaine Hydrochloride Injection recalled?
Amneal Pharmaceuticals, LLC recalled Ropivacaine Hydrochloride Injection in Apr 2025 — an FDA Class I recall (D-0402-2025) because Presence of Particulate Matter. Most serious — a reasonable probability that use will cause serious harm or death.
Why was Ropivacaine Hydrochloride Injection recalled?
Per the FDA enforcement record, the reason for recall D-0402-2025 was: Presence of Particulate Matter
Is a recalled Ropivacaine Hydrochloride Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Ropivacaine Hydrochloride Injection are affected?
Distributed: Nationwide in the US. The recall covers these lots — Lot #'s: AL240003, AL240004, Exp.: 01/31/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0402-2025.

Source: openFDA Drug Enforcement record D-0402-2025

← All drug recalls